A phase Ia/Ib, open label, multicenter, dose -escalation study of BI 907828 (MDM2-p53 antagonist) in adult patients with advanced or metastatic solid tumors Meeting Abstract
| Authors: | Chong, C. R.; Bauer, T. M.; Laurie, S. A.; Patel, M. R.; Yamamoto, N.; Davenport, T.; Geng, J.; Gibson, N.; Vallaster, M. P.; LoRusso, P. |
| Abstract Title: | A phase Ia/Ib, open label, multicenter, dose -escalation study of BI 907828 (MDM2-p53 antagonist) in adult patients with advanced or metastatic solid tumors |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 189s |
| Language: | English |
| ACCESSION: | WOS:000487345803309 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS3166 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS3166 -- Source: Wos |
